Overview

Bioavailability Study of Oral OZ439 Prototype Formulations Administered With Piperaquine Phosphate (PQP)

Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
A single dose study to investigate how different formulations of OZ439 co-administered with PQP tablest are processed by the body when taken without food
Phase:
Phase 1
Details
Lead Sponsor:
Medicines for Malaria Venture
Collaborator:
Quotient Clinical
Treatments:
Artefenomel
Piperaquine